Intellectual Property India Publishes Patent Application for 'Compositions Comprising Octadecaneuropeptides (Odn) And Synthetic Derivatives Thereof And Methods Of Use For Modulation Of Food Intake, Obesity, Body Weight, Nausea, And Emesis' Filed by The Trustees Of The University Of Pennsylvania; and Syracuse University

MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517056644 A) filed by The Trustees Of The University Of Pennsylvania; and Syracuse University, Philadelphia, on June 12, for 'compositions comprising octadecaneuropeptides (odn) and synthetic derivatives thereof and methods of use for modulation of food intake, obesity, body weight, nausea, and emesis.'

Inventor(s) include Hayes, Matthew, R.; Doyle, Robert, P.; Geisler, Caroline; Chichura, Kylie, S.; Reiner, Benjamin, C.; and Crist, Richard, C.

The application for the patent was published on Aug. 22, under issue no. 34/2025.

According to the abstract released by the Intellectual Property India: "Compositions and methods for the management and treatment of obesity, metabolic disorders, nausea and emesis using a ODN peptides and synthetic derivatives thereof are disclosed."

The patent application was internationally filed on Nov. 20, 2023, under International application No.PCT/US2023/080550.

Disclaimer: Curated by HT Syndication.